Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-09-28
1993-01-05
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514382, 514340, 548252, 548146, 548215, 548240, 546276, A61K 3141, C07D40112, C07D40314, C07D41314, C07D41414
Patent
active
051770962
ABSTRACT:
Angiotensin II receptor antagonists having the formula: ##STR1## which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and methods of using these compounds to produce angiotensin II receptor antagonism in mammals.
REFERENCES:
patent: 4340598 (1982-07-01), Furukawa et al.
patent: 4355040 (1982-10-01), Furukawa et al.
patent: 4539410 (1985-09-01), Renfroe
patent: 4880804 (1989-11-01), Carini et al.
patent: 4882342 (1989-11-01), von der Saal
Glennon et al., "N-(phtalimidoalkyl) Derivatives of Serotonergic Agents", J. Med. Chem., vol. 32, pp. 1921-1926 (Aug. 1989).
Glennon et al., "Central Serotonin Receptors as Targets for Drug Research", J. Med. Chem., vol. 30, pp. 1-12 (Jan. 1987).
Keenan Richard M.
Weinstock Joseph
Lentz Edward T.
McCarthy Mary E.
SmithKline Beecham Corporation
Springer David B.
Venetianer Stephen
LandOfFree
Substituted 5-((tetrazolyl)alkenyl)imidazoles and pharmaceutical does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 5-((tetrazolyl)alkenyl)imidazoles and pharmaceutical, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 5-((tetrazolyl)alkenyl)imidazoles and pharmaceutical will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2390788